Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.

Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH, Twisk JW, Anderson AK, Coombes L, Breen M, Hargrave OJ, Hemsley J, Craig F, Cruz O, Kaspers GJ, van Vuurden DG, Hargrave DR; SIOPE DIPG Network.

Neuro Oncol. 2016 Apr;18(4):582-8. doi: 10.1093/neuonc/nov250. Epub 2015 Oct 11.

PMID:
26459800
2.

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.

de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ; CCX140-B Diabetic Nephropathy Study Group.

Lancet Diabetes Endocrinol. 2015 Sep;3(9):687-96. doi: 10.1016/S2213-8587(15)00261-2. Epub 2015 Aug 9.

PMID:
26268910
3.

Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.

Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group.

Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9.

4.

Stroboscopic detection of nuclear resonance in an arbitrary scattering channel.

Deák L, Bottyán L, Callens R, Coussement R, Major M, Nasu S, Serdons I, Spiering H, Yoda Y.

J Synchrotron Radiat. 2015 Mar;22(2):385-92. doi: 10.1107/S1600577514026344. Epub 2015 Jan 28.

PMID:
25723940
6.

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.

Lincoff AM, Tardif JC, Schwartz GG, Nicholls SJ, Rydén L, Neal B, Malmberg K, Wedel H, Buse JB, Henry RR, Weichert A, Cannata R, Svensson A, Volz D, Grobbee DE; AleCardio Investigators.

JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.

PMID:
24682069
7.

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.

Wilding JP, Woo V, Rohwedder K, Sugg J, Parikh S; Dapagliflozin 006 Study Group.

Diabetes Obes Metab. 2014 Feb;16(2):124-36. doi: 10.1111/dom.12187. Epub 2013 Aug 29.

PMID:
23911013
8.

Subependymal giant cell astrocytoma with atypical clinical and pathological features: a diagnostic pitfall.

Svajdler M Jr, Deák L, Rychlý B, Talarčík P, Fröhlichová L.

Cesk Patol. 2013 Apr;49(2):76-9.

PMID:
23641712
9.

GINA--a polarized neutron reflectometer at the Budapest Neutron Centre.

Bottyán L, Merkel DG, Nagy B, Füzi J, Sajti S, Deák L, Endrőczi G, Petrenko AV, Major J.

Rev Sci Instrum. 2013 Jan;84(1):015112. doi: 10.1063/1.4770129.

PMID:
23387700
10.

Switching reciprocity on and off in a magneto-optical x-ray scattering experiment using nuclear resonance of α-(57)Fe foils.

Deák L, Bottyán L, Fülöp T, Kertész G, Nagy DL, Rüffer R, Spiering H, Tanczikó F, Vankó G.

Phys Rev Lett. 2012 Dec 7;109(23):237402. Epub 2012 Dec 4.

PMID:
23368265
11.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators.

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

12.

[Reflections of a clinician on the switch from human to analogue insulin treatment].

Deák L.

Orv Hetil. 2012 Oct 7;153(40):1589-93. Hungarian.

PMID:
23022882
13.

Metronomic chemotherapy with the COMBAT regimen in advanced pediatric malignancies: a multicenter experience.

Zapletalova D, André N, Deak L, Kyr M, Bajciova V, Mudry P, Dubska L, Demlova R, Pavelka Z, Zitterbart K, Skotakova J, Husek K, Martincekova A, Mazanek P, Kepak T, Doubek M, Kutnikova L, Valik D, Sterba J.

Oncology. 2012;82(5):249-60. doi: 10.1159/000336483. Epub 2012 Apr 24.

PMID:
22538363
14.

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.

Wilding JP, Woo V, Soler NG, Pahor A, Sugg J, Rohwedder K, Parikh S; Dapagliflozin 006 Study Group.

Ann Intern Med. 2012 Mar 20;156(6):405-15. doi: 10.7326/0003-4819-156-6-201203200-00003.

PMID:
22431673
15.

High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.

Balogh Z, Reiniger L, Rajnai H, Csomor J, Szepesi A, Balogh A, Deák L, Gagyi E, Bödör C, Matolcsy A.

Leuk Lymphoma. 2011 Jun;52(6):1080-4. doi: 10.3109/10428194.2011.555889. Epub 2011 Mar 21.

PMID:
21417824
16.

Electron proportional gas counter for linear and elliptical Mössbauer polarimetry.

Tanczikó F, Sajti S, Deák L, Merkel DG, Endroczi G, Nagy DL, Bottyán L, Olszewski W, Szymański K.

Rev Sci Instrum. 2010 Feb;81(2):023302. doi: 10.1063/1.3294425.

PMID:
20192487
17.

Avosentan reduces albumin excretion in diabetics with macroalbuminuria.

Wenzel RR, Littke T, Kuranoff S, Jürgens C, Bruck H, Ritz E, Philipp T, Mitchell A; SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators.

J Am Soc Nephrol. 2009 Mar;20(3):655-64. doi: 10.1681/ASN.2008050482. Epub 2009 Jan 14.

18.

Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.

Gagyi E, Balogh Z, Bödör C, Timár B, Reiniger L, Deák L, Csomor J, Csernus B, Szepesi A, Matolcsy A.

Haematologica. 2008 Dec;93(12):1822-8. doi: 10.3324/haematol.13239. Epub 2008 Oct 22.

19.

Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial.

Menne J, Farsang C, Deák L, Klebs S, Meier M, Handrock R, Sieder C, Haller H.

J Hypertens. 2008 Sep;26(9):1860-7. doi: 10.1097/HJH.0b013e32830508aa.

PMID:
18698222
20.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk